Pacific Biosciences Of California ROA 2009-2018 | PACB

Current and historical return on assets (ROA) values for Pacific Biosciences Of California (PACB) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Pacific Biosciences Of California ROA for the three months ending June 30, 2018 was -60.07%.
Pacific Biosciences Of California ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-06-30 $-0.09B $0.14B -60.40%
2018-03-31 $-0.09B $0.16B -58.40%
2017-12-31 $-0.09B $0.14B -60.39%
2017-09-30 $-0.09B $0.16B -59.67%
2017-06-30 $-0.09B $0.18B -57.05%
2017-03-31 $-0.08B $0.14B -53.24%
2016-12-31 $-0.07B $0.14B -49.49%
2016-09-30 $-0.06B $0.15B -37.74%
2016-06-30 $-0.04B $0.16B -27.07%
2016-03-31 $-0.03B $0.14B -25.64%
2015-12-31 $-0.03B $0.13B -28.57%
2015-09-30 $-0.05B $0.10B -45.90%
2015-06-30 $-0.06B $0.10B -53.45%
2015-03-31 $-0.07B $0.11B -55.83%
2014-12-31 $-0.07B $0.12B -51.26%
2014-09-30 $-0.06B $0.12B -48.58%
2014-06-30 $-0.08B $0.13B -53.76%
2014-03-31 $-0.08B $0.14B -53.90%
2013-12-31 $-0.08B $0.14B -55.42%
2013-09-30 $-0.08B $0.15B -59.61%
2013-06-30 $-0.09B $0.13B -62.32%
2013-03-31 $-0.09B $0.14B -59.86%
2012-12-31 $-0.10B $0.13B -59.10%
2012-09-30 $-0.10B $0.15B -52.53%
2012-06-30 $-0.10B $0.17B -49.70%
2012-03-31 $-0.10B $0.20B -44.74%
2011-12-31 $-0.11B $0.22B -43.78%
2011-09-30 $-0.12B $0.24B -45.02%
2011-06-30 $-0.13B $0.26B -54.92%
2011-03-31 $-0.15B $0.28B -81.12%
2010-12-31 $-0.14B $0.31B -128.44%
2010-09-30 $-0.10B $0.13B -320.00%
2010-06-30 $-0.09B $0.00B inf%
2010-03-31 $-0.06B $0.00B -194.69%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.590B $0.093B
Pacific Biosciences of California, Inc. is engaged in the development, manufacture and commercialization of its single molecule, real-time, or SMRT technology-an integrated platform for genetic analysis. The SMRT technology uses the natural processing power of enzymes, combined with specially designed reagents and detection systems, to record individual biochemical events as they occur. The Company's technology platform comprises of the SMRT cells, Phospholinked nucleotides and the PacBio RS (an instrument that conducts, monitors and analyzes single molecule biochemical reactions in real time). Its product will find its application in both research institutions and commercial companies, including genome centers, government and academic institutions, genomic service providers, pharmaceutical companies and agriculture companies. Pacific Biosciences of California, Inc. is headquartered in Menlo Park, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $94.718B 22.72
Intuitive Surgical (ISRG) United States $61.755B 58.95
Edwards Lifesciences (EW) United States $30.784B 34.67
Fresenius Medical Care (FMS) Germany $30.559B 21.58
IDEXX Laboratories (IDXX) United States $19.551B 59.42
ABIOMED (ABMD) United States $17.362B 142.24
DexCom (DXCM) United States $11.769B 0.00
Teleflex (TFX) United States $11.435B 27.20
Hologic (HOLX) United States $11.231B 19.11
Varian Medical Systems (VAR) United States $9.888B 24.89
STERIS (STE) United Kingdom $9.320B 25.64
Masimo (MASI) United States $6.246B 41.59
LivaNova (LIVN) United Kingdom $5.709B 34.06
Integra LifeSciences Holdings (IART) United States $5.388B 27.88
Globus Medical (GMED) United States $5.333B 35.48
Penumbra (PEN) United States $4.900B 445.44
Inogen (INGN) United States $4.526B 119.76
Cantel Medical (CMD) United States $3.666B 36.93
Wright Medical Group (WMGI) Netherlands $3.033B 0.00
Halyard Health (AVNS) United States $2.915B 23.99
Integer Holdings (ITGR) United States $2.479B 22.44
Glaukos (GKOS) United States $2.207B 0.00
Opko Health (OPK) United States $2.166B 0.00
Tandem Diabetes Care (TNDM) United States $2.062B 0.00
Nevro (NVRO) United States $1.659B 0.00
Mazor Robotics (MZOR) Israel $1.526B 0.00
AxoGen (AXGN) United States $1.355B 0.00
Luminex (LMNX) United States $1.254B 36.97
CryoLife (CRY) United States $1.234B 108.23
Tactile Systems Technology (TCMD) United States $1.215B 207.06
K2Ms (KTWO) United States $1.195B 0.00
Natus Medical (BABY) United States $1.110B 23.55
Orthofix (OFIX) United States $1.052B 32.03
TransEnterix (TRXC) United States $1.026B 0.00
Accelerate Diagnostics (AXDX) United States $0.920B 0.00
Intersect ENT (XENT) United States $0.901B 0.00
AngioDynamics (ANGO) United States $0.774B 27.07
ViewRay (VRAY) United States $0.709B 0.00
Mesa Laboratories (MLAB) United States $0.686B 42.40
Sientra (SIEN) United States $0.676B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.432B 0.00
OrthoPediatrics (KIDS) United States $0.427B 0.00
Neuronetics (STIM) United States $0.425B 0.00
Quotient (QTNT) Switzerland $0.375B 0.00
Veracyte (VCYT) United States $0.375B 0.00
GenMark Diagnostics (GNMK) United States $0.348B 0.00
Accuray (ARAY) United States $0.332B 0.00
Fluidigm (FLDM) United States $0.321B 0.00
Nuvectra (NVTR) United States $0.313B 0.00
RTI Surgical (RTIX) United States $0.300B 59.25
IRadimed (IRMD) United States $0.293B 105.58
Corindus Vascular Robotics (CVRS) United States $0.257B 0.00
CRH Medical (CRHM) Canada $0.251B 31.45
SeaSpine Holdings (SPNE) United States $0.244B 0.00
T2 Biosystems (TTOO) United States $0.221B 0.00
Helius Medical Technologies (HSDT) United States $0.205B 0.00
Pulse Biosciences (PLSE) United States $0.193B 0.00
Invuity (IVTY) United States $0.178B 0.00
RA MEDICAL SYST (RMED) United States $0.138B 0.00
Apollo Endosurgery (APEN) United States $0.138B 0.00
Alphatec Holdings (ATEC) United States $0.136B 0.00
Ekso Bionics Holdings (EKSO) United States $0.130B 0.00
Second Sight Medical Products (EYES) United States $0.114B 0.00
Sensus Healthcare (SRTS) United States $0.111B 0.00
Viveve Medical (VIVE) United States $0.109B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.108B 0.00
Biosig Technologies (BSGM) United States $0.076B 0.00
EDAP TMS (EDAP) France $0.075B 0.00
ConforMIS (CFMS) United States $0.060B 0.00
Electromed (ELMD) United States $0.056B 27.92
Navidea Biopharmaceuticals (NAVB) United States $0.054B 0.00
Restoration Robotics (HAIR) United States $0.053B 0.00
OBALON THERPTCS (OBLN) United States $0.049B 0.00
Neovasc (NVCN) Canada $0.048B 0.00
Xtant Medical Holdings (XTNT) United States $0.045B 0.00
Vermillion (VRML) United States $0.043B 0.00
Titan Medical (TMDI) Canada $0.031B 0.00
Lianluo Smart (LLIT) China $0.030B 0.00
PAVmed (PAVM) United States $0.030B 0.00
ReWalk Robotics (RWLK) Israel $0.029B 0.00
Dynatronics (DYNT) United States $0.025B 0.00
DarioHealth (DRIO) Israel $0.020B 0.00
Presbia (LENS) Ireland $0.020B 0.00
American Shared Hospital Services (AMS) United States $0.019B 15.45
Nanovibronix (NAOV) United States $0.017B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Bioanalytical Systems (BASI) United States $0.014B 0.00
Avinger (AVGR) United States $0.013B 0.00
ENDRA Life Sciences (NDRA) United States $0.011B 0.00
Micron Solutions (MICR) United States $0.010B 0.00
Allied Healthcare Products (AHPI) United States $0.008B 0.00
Atossa Genetics (ATOS) United States $0.008B 0.00
Cesca Therapeutics (KOOL) United States $0.008B 0.00
Sunshine Heart Inc (CHFS) United States $0.008B 0.00
InspireMD (NSPR) Israel $0.005B 0.00
Amedica (AMDA) United States $0.004B 0.00
EnteroMedics (RSLS) United States $0.000B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00